Private Placement

A $33M C-PACE deal for a Deepak Chopra-affiliated resort shows how innovative financing is reshaping real estate development in a tight market.

A new $50M fund unites venture capital with Canada's top cancer charities, aiming to fast-track lab discoveries into life-saving patient treatments.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

Enlight Renewable Energy posts strong Q1 results, with underlying profits surging 76% despite a misleading net income dip, and reaffirms its 2026 outlook.

neurocare's TMS device approval marks a major shift in the Kingdom's approach to depression, prioritizing non-invasive, tech-driven solutions.

The clean energy vehicle company is assembling a top-tier team to develop hydrogen-powered drones, aiming for a slice of the $182 billion UGV market.

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.

The cloud storage firm topped Q1 estimates and turned a non-GAAP profit, crediting a surge in AI clients drawn to its low-cost, high-performance data platform.

Valion Bio's new General Counsel, a rare blend of scientist and lawyer, is poised to navigate its radiation drug through the FDA's complex Animal Rule.

A junior miner strikes bonanza-grade silver and critical cobalt in a historic district, positioning itself to capitalize on a sixth straight year of market deficits.

With new backing from Bain Capital and Sixth Street, the $1.7B remodeler aims to expand its national footprint and tech-driven, people-first business model.

Scott Drennan takes the helm at Otto Aerospace, tasked with turning the visionary, ultra-efficient Phantom 3500 jet from concept to certified reality.

A new $100M fund is ditching traditional VC models, offering infrastructure capital to lure deep tech firms and reshape New Mexico’s economic landscape.

A new anechoic chamber in Syracuse allows Hidden Level to fast-track advanced RF systems, bolstering U.S. defenses against growing unmanned aerial threats.

The clinical-stage biotech adds seasoned veterans from Eli Lilly and Iovance to accelerate its promising DNA Damage Response pipeline toward commercialization.

An award for Lil Big Things reveals a new reality: AI is forcing brands to refresh marketing quarterly. Here’s how agile agencies are keeping pace.

A landmark partnership between Propella Group and TISTR aims to unlock Thailand's hidden scientific gems, creating a pipeline for global VCs.